29
Modifiable risk factors for AMD
References:
1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration.
N Engl J Med 2008; 358 (24): 2606-2617.
2. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly
SP. Smoking and age-related macular degeneration: a review of as-
sociation. Eye 2005; 19 (9): 935-944.
3. Chang MA, Bressler SB, Munoz B, West SK. Racial differences and
other risk factors for incidence and progression of age-related macu-
lar degeneration: Salisbury Eye Evaluation (SEE) Project. Invest
Ophthalmol Vis Sci 2008; 49 (6): 2395-2402.
4. Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol
intake, estrogen use, and age-related macular degeneration in Lati-
nos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006; 141
(1): 79-87.
5. Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, Kato
T, Kawata S, Kayama T, Tano Y, Mitchell P, Yamashita H, Wong TY.
Prevalence and risk factors for age-related macular degeneration in
an adult Japanese population: the Funagata study. Ophthalmology
2008; 115 (8): 1376-81, 1381.
6. Cackett P, Wong TY, Aung T, Saw SM, Tay WT, Rochtchina E,
Mitchell P, Wang JJ. Smoking, cardiovascular risk factors, and age-
related macular degeneration in Asians: the Singapore Malay Eye
Study. Am J Ophthalmol 2008; 146 (6): 960-967.
7. Krishnaiah S, Das T, Nirmalan PK, Nutheti R, Shamanna BR, Rao
GN, Thomas R. Risk factors for age-related macular degeneration:
findings from the Andhra Pradesh eye disease study in South India.
Invest Ophthalmol Vis Sci 2005; 46 (12): 4442-4449.
8. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-
related macular degeneration. The POLA Study. Pathologies Ocu-
laires Liées a l’Age. Arch Ophthalmol 1998; 116 (8): 1031-1035.
9. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley
M, Moore AT, Bird AC. Smoking and age related macular degen-
eration: the number of pack years of cigarette smoking is a major
determinant of risk for both geographic atrophy and choroidal neo-
vascularisation. Br J Ophthalmol 2006; 90 (1): 75-80.
10. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related
macular degeneration and smoking. The Rotterdam Study. Arch
Ophthalmol 1996; 114 (10): 1193-1196.
11. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective
study of cigarette smoking and age-related macular degeneration in
women. JAMA 1996; 276 (14): 1141-1146.
12. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence
of age-related maculopathy. The Beaver Dam Eye Study. Am J Epi-
demiol 1998; 147 (2): 103-110.
13. Chakravarthy U, Augood C, Bentham GC, de Jong PT, Rahu M,
Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR,
Vioque J, Young IS, Fletcher AE. Cigarette smoking and age-related
macular degeneration in the EUREYE Study. Ophthalmology 2007;
114 (6): 1157-1163.
14. Smith W, Mitchell P, Leeder SR. Smoking and age-related macu-
lopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996;
114 (12): 1518-1523.
15. Tan JS, Mitchell P, Kifley A, Flood V, Smith W, Wang JJ. Smoking
and the long-term incidence of age-related macular degeneration:
the Blue Mountains Eye Study. Arch Ophthalmol 2007; 125 (8):
1089-1095.
16. Tomany SC, Wang JJ, van Leeuwen R, Klein R, Mitchell P,
Vingerling JR, Klein BE, Smith W, de Jong PT. Risk factors for
incident age-related macular degeneration: pooled findings from 3
continents. Ophthalmology 2004; 111 (7): 1280-1287.
17. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year
incidence of age-related maculopathy: the Blue Mountains Eye
Study. Arch Ophthalmol 2002; 120 (10): 1357-1363.
18. Klein R, Klein BE, Tomany SC, Moss SE. Ten-year incidence of
age-related maculopathy and smoking and drinking: the Beaver
Dam Eye Study. Am J Epidemiol 2002; 156 (7): 589-598.
19. Francis PJ, George S, Schultz DW, Rosner B, Hamon S, Ott J,
Weleber RG, Klein ML, Seddon JM. The LOC387715 gene,
smoking, body mass index, environmental associations with ad-
vanced age-related macular degeneration. Hum Hered 2007; 63
(3-4): 212-218.
20. Seddon JM, George S, Rosner B, Klein ML. CFH gene variant,
Y402H, and smoking, body mass index, environmental asso-
ciations with advanced age-related macular degeneration. Hum
Hered 2006; 61 (3): 157-165.
21. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins
P, Wong F, Chen YS, Spencer K, Schnetz-Boutaud N, Haines JL,
Pericak-Vance MA. Cigarette smoking strongly modifies the as-
sociation of LOC387715 and age-related macular degeneration.
Am J Hum Genet 2006; 78 (5): 852-864.
22. Klein R. Overview of progress in the epidemiology of age-related
macular degeneration. Ophthalmic Epidemiol 2007; 14 (4): 184-
187.
23. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of
oxidative stress in the pathogenesis of age-related macular degen-
eration. Surv Ophthalmol 2000; 45 (2): 115-134.
24. Chiu CJ, Taylor A. Nutritional antioxidants and age-related cata-
ract and maculopathy. Exp Eye Res 2007; 84 (2): 229-245.
25. A randomized, placebo-controlled, clinical trial of high-dose sup-
plementation with vitamins C and E, beta carotene, and zinc for
age-related macular degeneration and vision loss: AREDS report
no. 8. Arch Ophthalmol 2001; 119 (10): 1417-1436. Erratum in:
2008; 126 (9): 1251.
26. Birlouez-Aragon I, Delcourt C, Tessier F, Papoz L. Associations of
age, smoking habits and diabetes with plasma vitamin C of elderly
of the POLA study. Int J Vitam Nutr Res 2001; 71 (1): 53-59.
27. Fletcher AE, Bentham GC, Agnew M, Young IS, Augood C,
Chakravarthy U, de Jong PT, Rahu M, Seland J, Soubrane G,
Tomazzoli L, Topouzis F, Vingerling JR, Vioque J. Sunlight ex-
posure, antioxidants, and age-related macular degeneration. Arch
Ophthalmol 2008; 126 (10): 1396-1403.
28. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz
L. Age-related macular degeneration and antioxidant status in the
POLA study. POLA Study Group. Pathologies Oculaires Liees a
l’Age. Arch Ophthalmol 1999; 117 (10): 1384-1390.
29. van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klav-
er CC, Hofman A, de Jong PT. Dietary intake of antioxidants and
risk of age-related macular degeneration. JAMA 2005; 294 (24):
3101-3107.
30. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of
current knowledge. Arch Ophthalmol 2006; 124 (7): 1038-1045.
